Saturday, 05 December 2020

SUSE extends help to medical device manufacturers

27 March 2020 | News

SUSE is offering free services for its open source operating system and container technologies to help speed time to market for medical device manufacturers

Image credit- shuttershock.com

Image credit- shuttershock.com

SUSE®, the world’s largest independent open source software company, has made a commitment to help all organizations that are producing medical devices to fight COVID-19. To that end, SUSE is offering free services such as support and maintenance for its operating system and container technologies to be embedded in and run those medical devices. These SUSE solutions are available immediately to help speed time to market for device manufacturers. Within India, SUSE has operations in Bengaluru, Mumbai and New Delhi.

“The current global pandemic requires more from us than simply trying to survive as companies and individuals,” said SUSE CEO Melissa Di Donato. “We are determined to help others as much as we can, doing what we do best. We have cutting-edge open source technology and know-how that can help others in the fight to save lives, and we will share it immediately and without charge. Our customers, partners and communities know of and share our commitment to making a difference – and that extends to our neighbors and fellow human beings around the world.”

SUSE Linux Enterprise is an operating system that can be built into, and help run, various kinds of devices, hardware and appliances. SUSE Embedded Linux features an optimized system footprint for specific products, including medical devices.

Container technologies from SUSE include SUSE CaaS Platform, which allows companies to use Kubernetes to more easily deploy and manage container-based applications and services, and SUSE Cloud Application Platform, which brings an advanced cloud native developer experience to Kubernetes so companies can get applications to the cloud and devices to market faster. These technologies bring security and reliability to any device they run on or manage.

SUSE customers in the pharmaceutical and research space, along with national laboratories all over the world, are already using supercomputers running SUSE Linux Enterprise to find solutions to issues posed by COVID-19, including prevention, treatment and cures.

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account






Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls